Should We Use Preoperative Epoetin-α in the Mildly Anemic Patient Undergoing Simultaneous Total Knee Arthroplasty?

Authors

Lawrence A Delasotta, Kingsbrook Jewish Medical Center, Brooklyn, NYFollow
Fabio Orozco, Rothman InstituteFollow
S Mehdi Jafari, Nirschl Orthopaedics at Virginia Hospital Center, Arlington, VA
Jamie L Blair, Rothman InstituteFollow
Alvin Ong, Rothman InstituteFollow

Document Type

Article

Publication Date

1-1-2013

Comments

This article has been peer reviewed. It was published in: The open orthopaedics journal

2013;7:47-50.

The published version is available at DOI: 10.2174/1874325001307010047. Copyright © Bentham Open

Abstract

Simultaneous knee arthroplasty is associated with significant blood loss. To prevent transfusion, three preoperative doses of epoetin-α were offered to mildly anemic simultaneous knee arthroplasty patients. A retrospective review, using ICD-9 codes, identified twenty patients from 2007-2009. Epoetin-α increased hemoglobin levels preoperatively (12.6 to 13.9, p

Recommended Citation

Delasotta, Lawrence A; Orozco, Fabio; Jafari, S Mehdi; Blair, Jamie L; and Ong, Alvin, "Should We Use Preoperative Epoetin-α in the Mildly Anemic Patient Undergoing Simultaneous Total Knee Arthroplasty?" (2013). Rothman Institute Faculty Papers. Paper 23.
https://jdc.jefferson.edu/rothman_institute/23